| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3956(01)00026-7 |
| P698 | PubMed publication ID | 11578639 |
| P50 | author | Enrico Smeraldi | Q72933640 |
| Alessandro Serretti | Q56380923 | ||
| P2093 | author name string | Lorenzi C | |
| Cusin C | |||
| Lattuada E | |||
| Lilli R | |||
| Mandelli L | |||
| Pisati E | |||
| P2860 | cites work | Heterogeneity of depression. Classification of depressive subtypes by longitudinal course | Q72495340 |
| Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association | Q72850842 | ||
| Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression | Q73068042 | ||
| Increased prevalence and earlier onset of mood disorders among relatives of prepubertal versus adult probands | Q73216627 | ||
| The depressive spectrum: diagnostic classification and course | Q28247081 | ||
| A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
| Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program | Q34298476 | ||
| PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy | Q36386005 | ||
| Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset | Q36767600 | ||
| Can antidepressants cause mania and worsen the course of affective illness? | Q39677054 | ||
| Tryptophan hydroxylase gene and major psychoses. | Q43687689 | ||
| Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. | Q43722419 | ||
| The family history method using diagnostic criteria. Reliability and validity | Q44578310 | ||
| Bipolar II illness: course and outcome over a five-year period. | Q50558688 | ||
| Recovery in major depressive disorder: analysis with the life table and regression models. | Q50590770 | ||
| Predictors of recurrence in affective disorder. A case register study. | Q50884870 | ||
| Recurrence in affective disorder. I. Case register study. | Q50897602 | ||
| Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). | Q50931611 | ||
| A prospective follow-up of patients with bipolar and primary unipolar affective disorder. | Q51053324 | ||
| A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression? | Q52016520 | ||
| Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects | Q52041342 | ||
| A family study of rapid-cycling bipolar illness. | Q52069888 | ||
| The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. | Q52074583 | ||
| Best estimate of lifetime psychiatric diagnosis: a methodological study. | Q52098061 | ||
| MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. | Q52305688 | ||
| Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. | Q55051636 | ||
| Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene | Q58451550 | ||
| Recovery From Major Depression | Q60447082 | ||
| Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression) | Q60447097 | ||
| Outcome of patients with chronic affective disorder: a five-year follow- up | Q60447111 | ||
| Impact of clinical variables on illness time course in mood disorders | Q60628033 | ||
| Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307 | Q60628045 | ||
| Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine | Q60631126 | ||
| Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder | Q63869212 | ||
| The long-term outcome of depressive illness | Q68088157 | ||
| The course of affective disorders | Q69002669 | ||
| Predictors of relapse in major depressive disorder | Q71108441 | ||
| Prediction of adolescent affective disorder: effects of prior parental affective disorders and child psychopathology | Q71275870 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of Psychiatric Research | Q6295810 |
| P1476 | title | Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders | |
| P478 | volume | 35 |
| Q43981238 | Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders |
| Q33697785 | CRY2 is associated with rapid cycling in bipolar disorder patients |
| Q44512845 | Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms |
| Q51778874 | Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. |
| Q34404924 | P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. |
| Q34155796 | Pharmacogenetics of antidepressant response |
| Q22242605 | Rapid cycling bipolar disorder - diagnostic concepts |
| Q33679424 | Role of variation in the serotonin transporter protein gene (SLC6A4) in trait disturbances in the ventral anterior cingulate in bipolar disorder |
| Q34369115 | Serotonin transporter gene polymorphisms and chronic illness of depression |
| Q35871016 | Structure-function associations in hippocampus in bipolar disorder |
| Q46828984 | Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms |
| Q37035245 | The serotonin transporter gene and effectiveness of SSRIs. |
Search more.